In analysis of pancreatic cancer cells, the overexpression of N-cadherin promotes the EMT process through the activation of the ErbB signaling pathway, creating possible new therapeutic targets for pancreatic cancer cells [81]. The gene discussed is CDH2; the disease is familial pancreatic carcinoma.